hi all, My husband has spent the last two months on Zytiga rechallenge after 5 rounds of docetaxel. He has had increased hip and back achiness, not severe pain. last month I thought with PSA jump from 45 to 57 that onc would change therapies, but he felt we could continue at that time with the zytiga/dexamethasone as Husband had only been on it for three weeks at that last appointment. his alkaline phosphates went up to 150's so I mentioned my concerns about not changing therapies, but Husband felt good, has energy, low pain so we stuck with it another month. with genetic testing and scans done prior to his next appointment which is next Tuesday,.
Genetic testing showed no markers at all, so good for our kids but not good for finding a different therapy.
Scans revealed a progression in his bone mets which had shrunk over the course of the last year and a half and in June had been holding steady. there is an increase in the size of the tumors in his bones in his spine and sternum and pelvis with two new spots in the ribs. obviously time for next therapy.
Last month I was leaning toward Radium 223 as that seems to be more directed to the bones. Doc had talked about a next step being Provenge or Cabazataxel. His reasoning in not jumping at Radium 223 was that many clinical trials often don't like you to have used it and it may preclude him from a trial, although the onc didn't have any specific trial in mind when I asked.
He has only two small lymph nodes that have not increased at all in the past six months and nothing in lungs of liver., so we are looking mostly at bone issue.
my concern is provenge will not attack the bone mets as well as Radium 223. and that chemo attacks the whole darn body and not just what is in the bone.
thoughts would be most welcome at this stage as we are trying to have good questions and ideas for his appointment on Tuesday Nov 5.